Clinical Trial Update: A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating blood concentrations after four oral doses of zibotentan in healthy non-Asian and Japanese participants. Liver Cirrho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Zibotentan (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Liver Cirrhosis | Phase 1 | Status: COMPLETED